Congresses and Events
![](https://www.bostonscientific.com/en-EU/medical-specialties/interventional-cardiology/intouch-newsletter/intouch-newsletter-q4-2016/congresses-and-events/_jcr_content/maincontent-par/image.img.intouch_nl_banner_en_1_645x175px_eu.jpg)
Clinical Evidence of the SYNERGY™ Stent for Optimal Healing and Safety: TCTMD Webcast
![TCTMD Webcast: : Clinical Evidence of the Synergy™ Stent](https://www.bostonscientific.com/en-EU/medical-specialties/interventional-cardiology/intouch-newsletter/intouch-newsletter-q4-2016/congresses-and-events/_jcr_content/maincontent-par/image_0.img.intouch_newsletter_issue_3_topic_1_1_960x480px_eu.jpg)
The SYNERGY™ Stent recently received FDA approval for use in patients with Diabetes Mellitus. This video presents novel aspects of the SYNERGY™ stent design, current clinical data supporting its safety and performance, angioscopic evidence of healing and real-world data.
Latest data at TCT 2016 confirms the safety of the WATCHMAN™ device in real life
![WATCHMAN™ LAA Closure device](https://www.bostonscientific.com/en-EU/medical-specialties/interventional-cardiology/intouch-newsletter/intouch-newsletter-q4-2016/congresses-and-events/_jcr_content/maincontent-par/image_1.img.intouch_newsletter_issue_3_topic_1_2_960x480px_eu.jpg)
Different experiences from Europe and US confirm the safety of the WATCHMAN™ device in real life, showing excellent real practice results. Watch Prof. Foley, Prof. Sievert and Prof. Bergmann discuss the EWOLUTION data and implications for clinical practice.
LOTUS™ Valve: Simplifying Treatment Strategies And Optimising Outcomes In The Real World
![LOTUS™ Valve wrap-up interview](https://www.bostonscientific.com/en-EU/medical-specialties/interventional-cardiology/intouch-newsletter/intouch-newsletter-q4-2016/congresses-and-events/_jcr_content/maincontent-par/image_2.img.intouch_newsletter_issue_3_topic_1_3_960x480px_eu.jpg)
A wrap up interview with Prof. Lars Sondergaard, Dr. Ted Feldman and Dr. Matthias Götberg, who discuss the technical features of the LOTUS™ valve system and how they translate into promising clinical outcomes . "Lotus™ is fully repositionable and fully retrievable which leads to a high degree of procedure success and also almost no mild paravalvular leak.", says Dr. Götberg.